40
Participants
Start Date
April 6, 2017
Primary Completion Date
December 11, 2018
Study Completion Date
May 11, 2019
humanized anti-PD-1 monoclonal antibody
humanized anti-PD-1 monoclonal antibody(JS001) is a programmed death-1 (PD-1) immune checkpoint inhibitor antibody, which selectively interferes with th combination of PD-1 with its ligands, PD-L1 and PD-L2, resulting in the activitation of lymphocytes and elimination of malignancy theoretically.
Beijing Cancer Hospital, Beijing
Shanghai Junshi Bioscience Co., Ltd.
OTHER
Peking University
OTHER